Further, in mouse models of Alzheimer’s disease and in clinical patients with mild cognitive impairment or early-stage Alzheimer’s disease, intranasal doses of insulin improve attention, memory, and cognitive function [13,16]. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.